Wells Fargo’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107 | Hold |
|
|||||
|
2025
Q1 | $103 | Hold |
|
|||||
|
2024
Q4 | $218 | Hold |
|
|||||
|
2024
Q3 | $122 | Hold |
|
|||||
|
2024
Q2 | $128 | Sell |
|
|||||
|
2024
Q1 | $535 | Buy |
|
|||||
|
2023
Q4 | $400 | Buy |
|
|||||
|
2023
Q3 | $424 | Buy |
|
|||||
|
2023
Q2 | $365 | Buy |
|
|||||
|
2023
Q1 | $268 | Hold |
|
|||||
|
2022
Q4 | $235 | Sell |
|
|||||
|
2022
Q3 | $0 | Buy |
|
|||||
|
2022
Q2 | $0 | Buy |
|
|||||
|
2022
Q1 | $1K | Hold |
|
|||||
|
2021
Q4 | $1K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $53K | Sell |
|
|||||
|
2020
Q4 | $200K | Buy |
|
|||||
|
2020
Q3 | $181K | Sell |
|
|||||
|
2020
Q2 | $200K | Buy |
|
|||||
|
2020
Q1 | $143K | Buy |
|
|||||
|
2019
Q4 | $152K | Sell |
|
|||||
|
2019
Q3 | $152K | Buy |
|
|||||
|
2019
Q2 | $180K | Buy |
|
|||||
|
2019
Q1 | $184K | Buy |
|
|||||
|
2018
Q4 | $64K | Buy |
|
|||||
|
2018
Q3 | $15K | Buy |
|
|||||
|
2018
Q2 | $6K | Sell |
|
|||||
|
2018
Q1 | $38K | Buy |
|